Hanmi Science stock: Share purchase agreement closes, 71.15% held
Published on 11/18/2026 at 01:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSShareholding and governance update
- The reported share purchase agreement involving Shin Dong-kook has closed.
- The controlling shareholder group retained 71.15 percent of Hanmi Science.
- The number of shares covered by major contracts fell by 1,382,832 from the previous report.
Hanmi Science said on Friday, November 13, that a share purchase agreement involving director Shin Dong-kook and Korea Value-Up Private Equity Partnership had closed, according to Biobook Media. The report said the controlling shareholder group retained 71.15 percent of the company after the transaction.
Ownership structure remains central
Song Young-sook and specially related parties held 48,659,690 common shares, equivalent to 71.15 percent, according to the report. The number of shares covered by major contracts fell by 1,382,832 from the previous report.
Shin Dong-kook reported the closing of the agreement with Korea Value-Up Private Equity Partnership and two other parties. The transaction keeps ownership structure and governance in focus for investors following Hanmi Science.
Healthcare portfolio spans several markets
Hanmi Science runs a South Korean healthcare portfolio covering premium soy milk, medical devices, food, digital transformation and a consumer platform, according to the Hanmi Science company profile. The company is headquartered in South Korea and operates alongside group businesses spanning pharmaceutical research and development, active pharmaceutical ingredients, pharmacy distribution and overseas operations. Its wider group also develops medicines in oncology, obesity, diabetes and rare diseases.
Hanmi Science ownership profile
- Company: Hanmi Science
- ISIN: KR7008930000
- Ticker: 008930
- Reported event: Share purchase agreement closing, November 13, 2026
- Controlling shareholder group: 71.15 percent
Hanmi Science operates within South Korea's healthcare market and the broader KOSPI market environment.
More corporate developments can be found in More news and analyses on Hanmi Science stock.
